Clearline Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-79,062
Closed -$3.86M 132
2022
Q4
$3.86M Buy
+79,062
New +$3.65M 0.69% 47
2017
Q4
Sell
-27,983
Closed -$460K 61
2017
Q3
$460K Buy
+27,983
New +$474K 0.33% 36

Other funds holding THC

Clearline Capital's THC Position: Q1 2023 in Review

Clearline Capital sold out of Tenet Healthcare (THC) in Q1 2023, closing a stake of 79,062 shares — an estimated $3.86M sold.

Clearline Capital first reported a position in THC in Q3 2017 and held it in 2 quarters. The position peaked at $3.86M in Q4 2022. 366 funds tracked by Wall St. Rank hold THC as of Q1 2023.

  • Clearline Capital reported no remaining Tenet Healthcare position as of Q1 2023 after selling out during the quarter.
  • Clearline Capital sold 79,062 Tenet Healthcare shares in Q1 2023, an estimated $3.86M.
  • Clearline Capital first reported a position in Tenet Healthcare in Q3 2017 and held it in 2 quarters.
  • Clearline Capital's Tenet Healthcare position peaked at $3.86M in Q4 2022.
  • 366 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2023.

Based on Clearline Capital's 13F filing for Q1 2023, filed 15 May 2023.